SABS
SAB Biotherapeutics, Inc. Common Stock
$3.97
-1.61%
-0.07
Notify me if price changes either direction
Buy SABS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
188.0M
Enterprise value
87.6M
Trailing PE
-1.0733695781749
Forward PE
-1.4416058
PEG Ratio
0.0074208267133081
Enterprise to EBITDA
-2.186
Enterprise to revenue
764.08
Price to book MRQ
1.1363636
Price to sales TTM
1639.4974
Financials
Fiscal Year Ends
2024-12-31
Most Recent Quarter (MRQ)
2025-09-30
Revenue (TTM)
114.7K
EBITDA
-40087972
Diluted EPS TTM
-1.56
Total Cash (MRQ)
110.9M
Current ratio (MRQ)
10.495
Operating Cash Flow (TTM)
-37530972
SABS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
November 2025
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
